109 related articles for article (PubMed ID: 25381141)
21. In vitro susceptibility of oral Candida to seven antifungal agents.
Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
[TBL] [Abstract][Full Text] [Related]
22. Fungicidal effect of photodynamic therapy against fluconazole-resistant Candida albicans and Candida glabrata.
Dovigo LN; Pavarina AC; Mima EG; Giampaolo ET; Vergani CE; Bagnato VS
Mycoses; 2011 Mar; 54(2):123-30. PubMed ID: 19889173
[TBL] [Abstract][Full Text] [Related]
23. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole.
Quan H; Cao YY; Xu Z; Zhao JX; Gao PH; Qin XF; Jiang YY
Antimicrob Agents Chemother; 2006 Mar; 50(3):1096-9. PubMed ID: 16495278
[TBL] [Abstract][Full Text] [Related]
24. Effect of chemosensitizers on minimum inhibitory concentrations of fluconazole in Candida albicans.
Bulatova NR; Darwish RM
Med Princ Pract; 2008; 17(2):117-21. PubMed ID: 18287794
[TBL] [Abstract][Full Text] [Related]
25. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
[TBL] [Abstract][Full Text] [Related]
26. [In vitro activity of amphotericin B, fluconazole and itraconazole against Candida glabrata strains isolated from clinical samples].
Hüseyin A; Sancak B; Arikan S
Mikrobiyol Bul; 2007 Apr; 41(2):235-44. PubMed ID: 17682710
[TBL] [Abstract][Full Text] [Related]
27. Structural optimization of berberine as a synergist to restore antifungal activity of fluconazole against drug-resistant Candida albicans.
Liu H; Wang L; Li Y; Liu J; An M; Zhu S; Cao Y; Jiang Z; Zhao M; Cai Z; Dai L; Ni T; Liu W; Chen S; Wei C; Zang C; Tian S; Yang J; Wu C; Zhang D; Liu H; Jiang Y
ChemMedChem; 2014 Jan; 9(1):207-16. PubMed ID: 24376206
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, antifungal activity of caffeic acid derivative esters, and their synergism with fluconazole and nystatin against Candida spp.
Sardi JC; Gullo FP; Freires IA; Pitangui NS; Segalla MP; Fusco-Almeida AM; Rosalen PL; Regasini LO; Mendes-Giannini MJ
Diagn Microbiol Infect Dis; 2016 Dec; 86(4):387-391. PubMed ID: 27638348
[TBL] [Abstract][Full Text] [Related]
29. In vitro activity of verapamil alone and in combination with fluconazole or tunicamycin against Candida albicans biofilms.
Yu Q; Ding X; Xu N; Cheng X; Qian K; Zhang B; Xing L; Li M
Int J Antimicrob Agents; 2013 Feb; 41(2):179-82. PubMed ID: 23265915
[TBL] [Abstract][Full Text] [Related]
30. Synergistic activities of fluconazole and voriconazole with terbinafine against four Candida species determined by checkerboard, time-kill, and Etest methods.
Cantón E; Pemán J; Gobernado M; Viudes A; Espinel-Ingroff A
Antimicrob Agents Chemother; 2005 Apr; 49(4):1593-6. PubMed ID: 15793148
[TBL] [Abstract][Full Text] [Related]
31. National surveillance of antifungal susceptibility of Candida species in South Korean hospitals.
Yoo JI; Choi CW; Lee KM; Kim YK; Kim TU; Kim EC; Joo SI; Yun SH; Lee YS; Kim BS
Med Mycol; 2009; 47(5):554-8. PubMed ID: 18819023
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, and biological evaluation of novel 1, 2, 4-triazole derivatives as antifungal agent.
Chai X; Yu S; Jiang Y; Zou Y; Wu Q; Zhang D; Jiang Y; Cao Y; Sun Q
Arch Pharm Res; 2012 Nov; 35(11):1895-901. PubMed ID: 23212630
[TBL] [Abstract][Full Text] [Related]
33. [Derivatization of berberine based on its synergistic antifungal activity with fluconazole against fluconazole-resistant Candida albicans].
Tian SJ; Gao Y; Zang CX; Cai Z; Ni TJ; Tan SL; Cao YB; Jiang YY; Zhang DZ
Yao Xue Xue Bao; 2014 Nov; 49(11):1563-8. PubMed ID: 25757282
[TBL] [Abstract][Full Text] [Related]
34. In vitro activity of fluconazole on Candida albicans.
Abecia LC; Arévalo JM; López MJ
Microbiologia; 1996 Dec; 12(4):613-20. PubMed ID: 9018696
[TBL] [Abstract][Full Text] [Related]
35. [Molecular epidemiology and antifungal susceptibility of Candida species isolated from urine samples of patients in intensive care unit].
Yüksekkaya S; Fındık D; Arslan U
Mikrobiyol Bul; 2011 Jan; 45(1):137-49. PubMed ID: 21341168
[TBL] [Abstract][Full Text] [Related]
36. [Biofilm production and antifungal susceptibility patterns of Candida species].
Yücesoy M; Karaman M
Mikrobiyol Bul; 2004; 38(1-2):91-8. PubMed ID: 15293907
[TBL] [Abstract][Full Text] [Related]
37. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
Messer SA; Diekema DJ; Boyken L; Tendolkar S; Hollis RJ; Pfaller MA
J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
[TBL] [Abstract][Full Text] [Related]
38. Antifungal activity of propolis against Candida species isolated from cases of chronic periodontitis.
Siqueira AB; Rodriguez LR; Santos RK; Marinho RR; Abreu S; Peixoto RF; Gurgel BC
Braz Oral Res; 2015; 29():. PubMed ID: 26154370
[TBL] [Abstract][Full Text] [Related]
39. Identification of Candida species isolated from patients in intensive care unit and in vitro susceptibility to fluconazole for a 3-year period.
Comert F; Kulah C; Aktas E; Eroglu O; Ozlu N
Mycoses; 2007 Jan; 50(1):52-7. PubMed ID: 17302749
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and bio-evaluation of C-1 alkylated tetrahydro-β-carboline derivatives as novel antifungal lead compounds.
Singh R; Jaisingh A; Maurya IK; Salunke DB
Bioorg Med Chem Lett; 2020 Feb; 30(3):126869. PubMed ID: 31870647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
